| Literature DB >> 21562116 |
Jérôme LeGoff1, Gérard Grésenguet, Chrysostome Gody, Jean De Dieu Longo, Nzambi Khonde, Helen A Weiss, Philippe Mayaud, Laurent Bélec.
Abstract
The BioPlex platform was evaluated for the detection of herpes simplex virus 2 (HSV-2) antibodies in sub-Saharan Africa individuals in comparison to clinicovirological standards and compared to HerpeSelect. The sensitivities and specificities were, respectively, 88.9% and 93.5% for BioPlex and 89.9% and 92.7% for HerpeSelect. The agreement between both assays was 95.7%.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21562116 PMCID: PMC3147317 DOI: 10.1128/CVI.05003-11
Source DB: PubMed Journal: Clin Vaccine Immunol ISSN: 1556-679X